Angle-supported intraocular-lens implantation for the correction of moderate to high myopia

• Kevin Matthew Serafin B. Panggat, MD
  Jesus Francisco, III, MD
  Pik Sha Chan, MD
  Harvey Siy Uy, MD

  Asian Eye Instititute
  Makati, Philippines
  
  Department of Ophthalmology
  and Visual Sciences
  University of the Philippines–
  Philippine General Hospital
  Manila, Philippines

ABSTRACT

Objective

This study evaluated the efficacy and safety of an angle-supported phakic intraocular lens (PIOL) for the treatment of moderate to high myopia.

Methods

This is a case series of 13 eyes of 8 patients with moderate to high myopia that underwent implantation of an acrylic, angle-supported PIOL. The main outcome measures were manifest refraction, uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), endothelial-cell count (ECC), intraocular pressure (IOP), and adverse events.

Results

This is a case series of 13 eyes of 8 patients with moderate to high myopia that underwent implantation of an acrylic, angle-supported PIOL. The main outcome measures were manifest refraction, uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), endothelial-cell count (ECC), intraocular pressure (IOP), and adverse events.

Conclusion

Acrylic angle-supported phakic intraocular lens (PIOL) implantation is an effective and safe method of correcting moderate to high myopia.